insights_auto
Why is STOK down 3.75%?
Dive Deeperchevron_right
STOK:NASDAQ
Stoke Therapeutics Inc
$24.37
arrow_downward
-3.75%(-0.95) 1D
$24.37
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 6, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for STOK...
Open
$25.58
High
$25.72
Low
$23.00
Mkt. cap
1.59B
Avg. vol.
911.22K
Volume
0.00
52-wk high
$40.22
52-wk low
$20.32
EPS
-$3.36
Beta
1.26
Shares outstanding
64.53M
No. of employees
170
Open
$25.58
High
$25.72
Low
$23.00
Mkt. cap
1.59B
Avg. vol.
911.22K
Volume
0.00
52-wk high
$40.22
52-wk low
$20.32
EPS
-$3.36
Beta
1.26
Shares outstanding
64.53M
No. of employees
170
News stories
From web sources and news partners
Stock Titan
·
21 hours ago
An inherited eye disease can cause irreversible vision loss. Stoke expects initial trial data in the first half of 2027.
Stock Traders Daily
·
1 day ago
(STOK) Risk Channels and Responsive Allocation
Stock Titan
·
1 day ago
A Dravet medicine trial will measure changes in four areas of thinking and behavior
About Stoke Therapeutics Inc
CEO-
Employees170
Founded2014
HeadquartersBedford, Massachusetts, United States
SectorBiotechnology
Websitestoketherapeutics.com